✅ out our review on the latest on the management of pulmonary embolism!
🫁 🩸 💉 💊
pmc.ncbi.nlm.nih.gov/articles/PMC...
The always impeccably dressed Samuel Bernard presenting #TEE in #cardiacarrest @umn-ccces.bsky.social. Is it too early or too late? @jameshorowitzmd.bsky.social @bkatli.bsky.social @taniaahuja.bsky.social #umnccces25 #cardiosky #cccsky
✅ out our 📄 on the past, present and future of cardiac intensive care unit pharmacists!
💊 🫀 🫶🏼
@jaccjournals.bsky.social
www.jacc.org/doi/abs/10.1...
at DOM research day!
(also, LGK! 🧡💙)
Fantastic session at #ACC25! Thank you @amandagarfinkel.bsky.social for addressing the emotional challenges of bad outcomes. Phenomenal panelists JasonKatzMD AnnGageMD @withheartdrmelanie.bsky.social & Dr. Landzberg sharing experiences and advice! @accintouch.bsky.social #CardioSky
Big thanks to my amazing panelists for an insightful discussion #ACC25! Your expertise and perspectives made it a truly great session! Grateful for the conversation and amazing audience! @accintouch.bsky.social @taniaahuja.bsky.social
(📸 courtesy of @jameshorowitzmd.bsky.social) #cardiosky
Check out 👀 this poster from @nyu.edu @taniaahuja.bsky.social on balancing drug-drug interactions between antiplatelet and antiretroviral therapy at #ACC25. Learn more about this important intersection of cardiovascular and HIV care on Sunday, March 30. @accintouch.bsky.social
Almost time #Chicago! Proud to have helped organize From a Spark to a Flame for #ACC25! A dynamic panel on cultivating unique interests and passions in your career. Join us Saturday, March 29 at 4:00 PM CDT at #ACC25 for expert insights. #CardioSky @accintouch.bsky.social @taniaahuja.bsky.social
watching #ThePitt and not one, but BOTH STEMIs, with & without ECMO, were loaded with chewable ASA 324 mg but 👏 no 👏 P2Y12inh 👏
love to see it 🫀 🫶🏼❤️🩹
are you at #SCCM2025 ?
come check out a presentation on the role of quinidine in the cardiac ICU from @nyulangone.bsky.social pharmacy PGY2 in critical care on Sunday 2/23 at 2:30!
@sccmcriticalcare.bsky.social @sccmjournals.bsky.social
abstract ➡️ journals.lww.com/ccmjournal/f...
We were featured! 🌟
journals.lww.com/cardiovascul...
150mg IV bolus, then 1mg/min for 6 hr, then 0.5mg/min for 18hr & transition to PO with bid or tid at end of this.
If awaiting ablation, or rates still > 110, may leave on IV longer at the 0.5.
For VT, or atrial in CICU we will leave at 1mg/min for longer, usually drop to 0.5 on day 2 or 3.
Hmm we rarely overlap, but if critically ill, in 💔 shock we use IV for > 1 day & likely saturate distribution. Plasma levels seem to not correlate with efficacy or toxicity, given distribution. We begin PO w/load (400 bid or tid) soon as IV completes to get to 5-10gm depending on arrhythmia.
do you use valproic acid In your ICUs to manage hyperactive delirium or agitation?
✅ out our experience ⬇️
journals.sagepub.com/doi/10.1177/...
What's the optimal timing of P2Y12 inhibitor for NSTEMI? ⏰
🫀In modern NSTEMI management, P2Y12 inhibitor before PCI is unnecessary
@jaccjournals.bsky.social @ahascience.bsky.social
#AHA24
www.jacc.org/doi/10.1016/...
check out our 📄 on digoxin loading doses for treatment of atrial arrhythmias in critically ill patients 🫀💛🫀
journals.lww.com/cardiovascul...
@jameshorowitzmd.bsky.social
Hypochloremia is associated with diuretic resistance. In 👇 study from Yale, hypochloremia was associated with poor diuretic efficiency (defined as mmol of UNa per doubling of loop diuretic dose). Of note - serum sodium was NOT associated with diuretic efficiency #cardiosky
Congratulations to @johnlsapp on the presentation and publication of VANISH-2.
First line VT ablation is associated with significant reduction in composite of death, VT, storm for patients with ischemic cardiomyopathy.
www.nejm.org/doi/full/10....
Check out our paper on DDI with antiretrovirals and antiplatelets 💊🫀
we found high incidence but unclear how much this correlates with MACE or 🩸
journals.lww.com/cardiovascul...
